Zyprexa and Sensipar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zyprexa (olanzapine) and Sensipar (cinacalcet hydrochloride). Common drug interactions include death among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people have when they take Zyprexa and Sensipar. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Zyprexa?

Zyprexa has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 64,724 Zyprexa users. Check the latest studies of Zyprexa.

What is Sensipar?

Sensipar has active ingredients of cinacalcet hydrochloride. It is often used in hyperparathyroidism secondary. eHealthMe is studying from 46,034 Sensipar users. Check the latest studies of Sensipar.



On Jul, 25, 2026

13 people who take Zyprexa and Sensipar together, and have interactions are studied.

Zyprexa and Sensipar drug interactions.

What are the common drug interactions of Zyprexa and Sensipar, by gender? *:

female:

  1. Death
  2. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  3. Dehydration (dryness resulting from the removal of water)
  4. Delirium (wild excitement)
  5. Diabetes mellitus inadequate control
  6. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  7. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  8. Disease progression
  9. Disturbance in attention
  10. Dry gangrene (diminished blood supply due to vascular problems)

male:

  1. Abdominal distension
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Hypoglycaemia (deficiency of glucose in the bloodstream)
  4. Pain in extremity
  5. Pancreatitis (inflammation of pancreas)
  6. Pancreatitis chronic (chronic inflammation of pancreas)
  7. Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)
  8. Renal failure (kidney dysfunction)
  9. Renal failure chronic (long lasting kidney dysfunction)
  10. Suicidal ideation

What are the common drug interactions of Zyprexa and Sensipar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Asthenia (weakness)
  2. Cardiac failure congestive
  3. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  4. Chest pain
  5. Decreased appetite
  6. Diarrhoea
  7. Dyspnoea (difficult or laboured respiration)
  8. Flushing (the warm, red condition of human skin)
  9. Hyperhidrosis (abnormally increased sweating)
  10. Hypotension (abnormally low blood pressure)

50-59:

  1. Abdominal distension
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Asterixis (flapping tremor, or liver flap)
  4. Atrioventricular block first degree (heart block first degree)
  5. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  6. Catheter sepsis (bacterial infection in blood due to catheter)
  7. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  9. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  10. Dysarthria (speech disorder)

60+:

  1. Acute respiratory failure
  2. Anaphylactic reaction (serious allergic reaction)
  3. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  4. Swelling face
  5. Unresponsive to stimuli
  6. Angioedema (rapid swelling of the dermis)
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Dyspnoea (difficult or laboured respiration)
  9. Hypotension (abnormally low blood pressure)
  10. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)

What are the existing conditions these people have? *

  1. Nephrogenic Anaemia (anaemia due to kidney disease): 1 person, 7.69%
  2. Hypercalcaemia (elevated calcium (ca+) level in the blood): 1 person, 7.69%
  3. High Blood Pressure: 1 person, 7.69%
  4. Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 1 person, 7.69%
  5. Depression: 1 person, 7.69%
  6. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Zyprexa and Sensipar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zyprexa and Sensipar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zyprexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sensipar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zyprexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sensipar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on olanzapine and cinacalcet hydrochloride (the active ingredients of Zyprexa and Sensipar, respectively), and Zyprexa and Sensipar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: